Real-World Utilization of Adalimumab Biosimilar (ABP 501) in Patients with Psoriasis in Europe

被引：0
|
作者：
Jin, Ran [1 ]
Wrest, Eleanor [2 ]
Haughton, James [2 ]
Piercy, James [2 ]
Meadows, Rachel [2 ]
Radziszewski, Waldemar [1 ]
机构：
[1] Amgen Inc, Thousand Oaks, CA USA
[2] Adelphi Real World, Bollington, England
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB216 / AB216
页数：1
相关论文
共 50 条
  • [41] Adalimumab Persistence and Its Biosimilar in Inflammatory Bowel Disease: A Real-World Study
    Fernandez-Cano, Maria Carmen
    Fernandez-Cano, Antonio Jesus
    Martin-Rodriguez, Maria Mar
    Sanchez-Capilla, Antonio Damian
    Cabello-Tapia, Maria Jose
    Redondo-Cerezo, Eduardo
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (02)
  • [42] LONG TERM EFFICACY AND SAFETY OF ABP 501 ADALIMUMAB BIOSIMILAR ON INFLAMMATORY BOWEL DIESASES: THE ADASWITCH STUDY
    Cingolani, A.
    Felice, C.
    Lombardi, G.
    Onidi, F. M.
    Checchin, D.
    Colucci, R.
    Grossi, L.
    Ferronato, A.
    Rocchi, C.
    Ascolani, M.
    Binaghi, L.
    Dore, M. F.
    Fanini, L.
    Bulajic, M.
    Mocci, G.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S138 - S138
  • [43] RELATIONSHIP BETWEEN PHARMACOKINETICS AND ANTI-DRUG ANTIBODY STATUS OF ABP 501, A BIOSIMILAR CANDIDATE TO ADALIMUMAB
    Kaur, P.
    Chow, V.
    Zhang, N.
    Markus, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 714 - 714
  • [44] Pharmacokinetic and Safety Similarity of High- and Low-Concentration Formulations of Adalimumab Biosimilar ABP 501
    Chow, Vincent
    Zhou, Muhan
    Mytych, Daniel
    Colbert, Alexander
    Miller, Mieke Jill
    Wala, Iwona
    Radziszewski, Waldemar
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4266 - 4268
  • [45] SWITCHING TO BIOSIMILAR ADALIMUMAB: A REAL WORLD STUDY
    Begum, Julie
    Nisar, Muhammad K.
    RHEUMATOLOGY, 2020, 59
  • [46] Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis
    Becciolini, Andrea
    Parisi, Simone
    Caccavale, Rosalba
    Bravi, Elena
    Lumetti, Federica
    Andracco, Romina
    Volpe, Alessandro
    Gardelli, Lucia
    Girelli, Francesco
    Di Donato, Eleonora
    Santilli, Daniele
    Lucchini, Gianluca
    Ditto, Maria Chiara
    Plate, Ilaria
    Arrigoni, Eugenio
    Mozzani, Flavio
    Riva, Michele
    Marchetta, Antonio
    Fusaro, Enrico
    Sandri, Gilda
    Salvarani, Carlo
    Paroli, Marino
    Ariani, Alarico
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (03):
  • [47] Systematic review of the real-world evidence of adalimumab safety in psoriasis registries
    Strober, B.
    Crowley, J.
    Langley, R. G.
    Gordon, K.
    Menter, A.
    Leonardi, C.
    Arikan, D.
    Valdecantos, W. C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (12) : 2126 - 2133
  • [48] Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real-world setting
    Papp, K. A.
    Gooderham, M. J.
    Albrecht, L. E.
    Raymond, M. -A.
    Lynde, C. W.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : 726 - 728
  • [49] Treatment switching among psoriasis patients treated with ixekizumab, secukinumab, and adalimumab in real-world settings
    Blauvelt, A.
    Shi, N.
    Burge, R.
    Malatestinic, W. N.
    Lew, C. R.
    Zimmerman, N. M.
    Amato, D.
    Zhu, B.
    Murage, M. J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 24 - 24
  • [50] Real-World Outcomes of Adalimumab Treatment for Moderate and Severe Psoriasis in Korean Patients (RAPSODI Study)
    Kim, Dong Hyun
    Son, Sang Wook
    Jeong, Ki-Heon
    Ahn, Jiyoung
    Lee, Eun-So
    Kim, Il-Hwan
    Ha Lee, Un
    Park, Hai-Jin
    Ko, Joo Yeon
    Kim, Byung-Soo
    Kim, Jin Ju
    Rashid, Javed
    Kim, Kwang Joong
    ANNALS OF DERMATOLOGY, 2023, 35 (02) : 107 - 115
12345